| Patents for C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961) |
|---|
| 05/15/2003 | CA2466284A1 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 05/13/2003 | US6562825 For treating inflammatory disease including asthma and allergic diseases, as well as autoimmune pathologies |
| 05/08/2003 | WO2003037872A1 Therapeutic quinoline compounds with 5-ht-antagonistic properties |
| 05/08/2003 | WO2003037871A1 Therapeutic quinolone compounds with 5-ht-antagonistic properties |
| 05/08/2003 | WO2003037852A1 Allenic aryl sulfonamide hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 05/08/2003 | WO2003037271A2 Compounds, pharmaceutical compositions and methods of use therefor |
| 05/08/2003 | CA2465350A1 Therapeutic quinoline compounds with 5-ht-antagonistic properties |
| 05/08/2003 | CA2465344A1 Therapeutic quinolone compounds with 5-ht-antagonistic properties |
| 05/08/2003 | CA2464727A1 Allenic aryl sulfonamide hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 05/07/2003 | EP1307460A1 Method for the production of imidazo-(1,2-c)(2,3)-benzodiazepines and intermediates in the production thereof |
| 05/07/2003 | EP0765314B1 Benzoheterocyclic derivatives useful as vasopressin or oxytocin modulators |
| 05/06/2003 | US6559140 Cyclic and bicyclic diamino histamine-3 receptor antagonists |
| 05/02/2003 | EP0738150B1 Bicyclic fibrinogen antagonists |
| 05/01/2003 | WO2003035602A1 Lipid modulators |
| 05/01/2003 | WO2002099388A3 Benzodiazepine bradykinin antagonists |
| 05/01/2003 | WO2001096318A8 Cyclic urea compounds and preparation thereof |
| 04/30/2003 | CN1414956A Substituted piperazine derivatives as MIP inhibitors |
| 04/30/2003 | CN1107061C Chemotaxis cell factor receptor-3 receptor antagonists |
| 04/30/2003 | CN1107056C Process for preparation of clonidine derivatives |
| 04/24/2003 | US20030078420 New derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 04/24/2003 | US20030078254 Tricyclic inhibitors of poly(ADP-ribose) polymerases |
| 04/22/2003 | US6552216 Molecular model for VLA-4 inhibitors |
| 04/22/2003 | US6552041 Cyclized amide derivatives useful for treating or preventing neuronal damage associated with neurological disease |
| 04/22/2003 | CA2239187C Inhibitors of farnesyl protein transferase |
| 04/17/2003 | WO2003031416A2 [[2-(amino-3,4-dioxo-1cyclobuten-1-yl)amino]alkyl]-acid derivatives for the treatment of pain |
| 04/17/2003 | WO2003031376A1 Solid phase synthesis of substituted 1,5-benzodiazepine-2-one and 1,5-benzothiazepine-2-one |
| 04/17/2003 | US20030073745 Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents, especially for cervical cancers and dysplasias |
| 04/16/2003 | EP0966449B1 1,4-diazacycloheptane derivatives and their use in hair oxidation dyes |
| 04/15/2003 | US6548495 Dihydro-benzo [B] [1,4] diazepin-2-one derivatives |
| 04/10/2003 | WO2003029232A1 Phenyl-piperazine derivatives as serotonin reuptake inhibitors |
| 04/10/2003 | WO2002094189A3 Compositions and methods for treating or preventing convulsions or seizures |
| 04/10/2003 | US20030069418 Ligands for cellular receptors, including opiate receptors; side effect reduction; base structure is a saturated nitrogen-containing ring substituted with a tertiary amide that is N-substituted with an arylalkyl group |
| 04/10/2003 | CA2462110E Phenyl-piperazine derivatives as serotonin reuptake inhibitors |
| 04/09/2003 | EP1299364A1 Benzodiazepines as inhibitors of hpv e1 helicase |
| 04/09/2003 | EP0842156B1 Novel n-(2,4-dioxo-2,3,4,5-tetrahydro-1h-1,5-benzodiazepin-3yl)-3-amides |
| 04/09/2003 | EP0674623B1 Bicyclic fibrinogen antagonists |
| 04/09/2003 | CN1409706A Calcium salts of 1,5-benzodiazepine derivatives, process for producing salts and drugs containing same |
| 04/08/2003 | US6545038 Heterocyclic metalloprotease inhibitors |
| 04/08/2003 | US6544985 For therapy of acute and/or chronic neurological disorders such as psychosis, schizophrenia, Alzheimer's disease, cognitive disorders and memory deficits |
| 04/08/2003 | US6544984 2,3,4,5-tetrahydro-1H-(1,4)benzodiazepine-3-hydroxamic acids |
| 04/04/2003 | WO2002030896A1 2,2-diphenylbutanamide derivatives and medicines containing the same |
| 04/04/2003 | CA2424979A1 2,2-diphenylbutanamide derivatives and medicines containing the same |
| 04/03/2003 | WO2000038618A3 SUCCINOYLAMINO BENZODIAZEPINES AS INHIBITORS OF Aβ PROTEIN PRODUCTION |
| 04/03/2003 | US20030065023 Anticancer agents, viricides, psychological disorders |
| 04/02/2003 | EP1296961A1 1,4-diazepan-2,5-dione derivatives and their use as nk-1 receptor antagonists |
| 04/02/2003 | EP1296960A2 5h-2,3-benzodiazepine antagonists of excitatory amino acid receptors |
| 04/02/2003 | CN1104418C Benzoheterocyclic derivatives |
| 03/27/2003 | WO2002078628A3 Cyanamide, alkoxyamino, and urea derivatives of 1,3-benzodiazapines as hiv reverse transcriptase inhibitors |
| 03/27/2003 | US20030060461 Cyclic diamine compound with condensed-ring groups |
| 03/27/2003 | US20030057826 1,4-diazepine derivatives useful as functional materials for use in organic electroluminescence devices |
| 03/26/2003 | WO2002026732A1 Benzodiazepine derivative |
| 03/26/2003 | EP1294702A1 Benzodiazepine derivatives as app modulators |
| 03/26/2003 | EP1294701A2 Bis-arylsulfones |
| 03/26/2003 | EP1294698A1 Fused azepine derivatives and their use as antidiuretic agents |
| 03/26/2003 | EP0986585B1 Use of ylides of phosphorus as slightly nuceophilic strong bases |
| 03/26/2003 | EP0833819B1 Novel n-(2-oxo-2,3,4,5-tetrahydro-1h-1,5-benzodiazepin-3yl)-3-amides |
| 03/26/2003 | CN1103775C Vitronectin receptor antagonists, their preparation and use |
| 03/26/2003 | CA2423902A1 Benzodiazepine derivative |
| 03/25/2003 | US6537959 Diazacycloalkanes, i.e., 1,4,6-trimethyl-6-(n-(pyridin-2-ylmethyl)-N-methylamino)-1,4 -diazacycloheptane; ligands in manganese, iron and cobalt transition metal complexes. |
| 03/20/2003 | WO2003022277A1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 03/20/2003 | US20030055093 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction |
| 03/20/2003 | US20030055048 Compositions and methods for treating or preventing convulsions or seizures |
| 03/19/2003 | EP1293207A1 Use of ritonavir (ABT-538) for improving the pharmacokinetics of drugs metabolized by cytochrome P450 in a method of treating aids |
| 03/18/2003 | US6534535 Inhibitors of factor Xa |
| 03/13/2003 | WO2003004472A8 Arylamines for the treatment of conditions associated with gsk-3 |
| 03/12/2003 | EP1289968A1 Cyclic urea compounds and preparation thereof |
| 03/12/2003 | EP1289966A1 SUBSTITUTED LACTAMS AS INHIBITORS OF A$g(b) PROTEIN PRODUCTION |
| 03/12/2003 | EP1289965A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists |
| 03/12/2003 | EP1289964A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists |
| 03/12/2003 | EP0789577B1 Synthesis of n-substituted oligomers |
| 03/06/2003 | WO2002072570A3 Non-imidazole compounds as histamine h3 antagonists |
| 02/27/2003 | WO2003015703A2 Compositions and methods relating to novel benzodiazepine compounds and targets thereof |
| 02/27/2003 | WO2002098865A3 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof |
| 02/27/2003 | CA2457405A1 Compositions and methods relating to benzodiazepine compounds |
| 02/26/2003 | CN1399634A Hydroxyalkanoyl aminolactams and related structure as inhibitors of A beta protein production |
| 02/25/2003 | US6525044 Treatment of neurological disorders related to beta -amyloid production such as Alzheimer's disease and Down's Syndrome. |
| 02/20/2003 | WO2003014093A1 Composition for dyeing keratinous fibres containing a paraphenylenediamine substituted by a diazacycloheptane radical |
| 02/20/2003 | WO2003013545A1 Novel benzo-fused heterocycles as endothelin antagonisits |
| 02/20/2003 | CA2454417A1 Novel benzo-fused heterocycles as endothelin antagonists |
| 02/19/2003 | EP1284140A2 Use of ritonavir (ABT-538) for improving the pharmacokinetics of drugs metabolized by cytochrome P450 in a method of treating aids |
| 02/18/2003 | US6521614 N-(amidinophenyl)cyclourea analogs as factor Xa inhibitors |
| 02/11/2003 | US6518310 Non-peptidic; inhibits trypsin-like protease, thrombin and embolus formation; anticoagulant |
| 02/06/2003 | US20030027807 Vitronectin receptor antagonists, their preparation and their use |
| 02/05/2003 | EP1280794A1 Diazacycloalkane derivatives as bleach catalyst and composition and method for bleaching a substrate |
| 02/05/2003 | EP1280523A2 Use of benzamide derivatives for the treatment of high ocular tension and glaucoma |
| 02/05/2003 | CN1395562A Nitrogenous cyclic compounds and pharmaceutical compositions containing the same |
| 02/05/2003 | CN1100748C Inhibition of matrix metalloproteases by 2-substituted-4-(4-substituted phenyl)-4-oxobutyric acids |
| 01/30/2003 | WO2003008390A1 Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy |
| 01/30/2003 | WO2002012247A1 Method for the production of imidazo-(1,2-c)(2,3)-benzodiazepines and intermediates in the production thereof |
| 01/30/2003 | CA2417804A1 Method for the production of imidazo-(1,2-c)(2,3)-benzodiazepines and intermediates in the production thereof |
| 01/23/2003 | US20030018024 Biphenyl vasopressin agonists |
| 01/22/2003 | EP1277729A1 Ppar (gamma) modulators |
| 01/21/2003 | US6509333 1-(3-methyl-1-(1,3-dihydro-1-methyl-2-oxo-5-phenyl-2H-1,4 -benzodiazepin-3-ylcarbamoyl)-butyl)-cyclopent-3-enecarboxylic amide, for example; gamma-secretase inhibitors; Alzhemier's disease, Down's Syndrome |
| 01/21/2003 | US6509331 Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
| 01/21/2003 | US6509328 Glutamate receptor antagonists |
| 01/16/2003 | WO2003004480A2 Substituted piperazine and diazepanes as histamine h3 receptor agonists |
| 01/16/2003 | WO2003004472A1 Arylamines for the treatment of conditions associated with gsk-3 |
| 01/16/2003 | CA2452686A1 Arylamines for the treatment of conditions associated with gsk-3 |
| 01/15/2003 | EP0925287B1 Heterocyclic metalloprotease inhibitors |
| 01/15/2003 | EP0907643B1 Compounds with growth hormone releasing properties |